National Institute of Diabetes and Digestive and Kidney Diseases

What National Institute of Diabetes and Digestive and Kidney Diseases does

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is one of 27 institutes and centers of the U.S. National Institutes of Health (NIH), itself an agency of the Department of Health and Human Services. Established in 1950 and headquartered in Bethesda, Maryland, NIDDK conducts and funds medical research and research training across diabetes, digestive diseases, kidney disease, obesity, and hematologic diseases, with additional work in endocrine, metabolic, urologic, liver, and nutritional disorders. Its intramural Division of Intramural Research operates alongside a large extramural grant program that funds Research Centers, clinical trial networks (DPP, DCCT/EDIC, Look AHEAD, TEDDY, TrialNet, LIFE-Moms), and investigator-initiated studies across U.S. academic institutions.

NIDDK's core infrastructure includes the NIDDK Central Repository, which makes 173 studies with data and 111 studies with biospecimens available to qualified researchers, the dkNET information network for cross-resource search, the Health Information Center for science-based patient and provider education, and the Mouse Metabolic Phenotyping Centers. The institute maintains recognized quality certifications (Core Trustworthy Data Repository, World Data System membership) and is tightening access controls to NIST SP 800-171 / ISO 27001 standards effective April 2026. As a federal entity, NIDDK does not sell products or services; outputs are funded through congressional appropriations and provided at no cost to qualifying researchers, patients, and health professionals.

Name

National Institute of Diabetes and Digestive and Kidney Diseases

Legal name

National Institute of Diabetes and Digestive and Kidney Diseases

Website

https://niddk.nih.gov

Company type

Private

Founded year

1950

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

NIDDK is a U.S. federal research institute within NIH that funds and conducts medical research across diabetes, digestive, kidney, obesity, and hematologic diseases, operating the Central Repository, dkNET, and a national network of Research Centers to serve researchers, clinicians, and patients.

Ownership category

akta.pro rank

Product category

Government Biomedical Research

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAJAIAA

National Public Health Reference Laboratories

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

SECONDARYHLAHAHAJ

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)

SECONDARYHLAKAHAA

General Nephrology Practice

Healthcare & Life Sciences/Specialist Medical Practice/Nephrology

SECONDARYHLAGADAF

Molecular & Genetic Testing (PCR/NGS/qPCR)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical Services

SECONDARYHLAKADAA

Diabetes (General)

Healthcare & Life Sciences/Specialist Medical Practice/Endocrinology & Diabetes

Keywords

• Biomedical research institute
• Clinical trial funding
• Health information dissemination
• Medical research grants
• Disease research programs

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Distribution channels5 records

Marketing channels9 records

Core offering

NIDDK is a U.S. federal research institute that conducts and supports medical research, research training, and science-based health information dissemination focused on diabetes, digestive diseases, kidney disease, obesity, and hematologic diseases. It funds investigator-initiated research through grants, operates the NIDDK Central Repository providing access to clinical trial data and biospecimens from 173+ studies, supports a network of Research Centers, and publishes evidence-based health information for patients and healthcare professionals.

Product overview

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is a federal research institute, not a commercial product company. Its offerings consist of publicly-funded research infrastructure, health information resources, and data sharing services. The core offerings include the NIDDK Central Repository for clinical research data and biospecimens, dkNET for searching biomedical resources, the Research Centers Program supporting multidisciplinary medical research across diabetes, digestive, kidney, and urologic diseases, and the Health Information Center providing science-based health information. The NIDDK also funds research on automated insulin delivery systems (artificial pancreas) using AI algorithms and hosts educational programs like the dkNET Summer of Data Student Program and Data Science Webinar Series.

Differentiator

Problem solved

Functional benefit

Brands

• NIDDK Central Repository: An internal division that provides access to data and biospecimens from NIDDK-funded studies for research purposes.

Products and services

• NIDDK Central Repository (NIDDK-CR)

Quantifiable outcome

• 21% lower risk of developing two chronic conditions with intensive lifestyle intervention
• +3 more outcomes

Segments9 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability8 records

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• VivlicoreStrategic or Co-development PartnerNIDDK Central Repository joined Vivli, a global clinical research data sharing platform, as part of the NIH Office of Data Science Strategy's Generalist Repository Ecosystem Initiative (GREI). This partnership improves discoverability and reuse of NIDDK resources, making data more FAIR (Findable, Accessible, Interoperable, and Reusable) and maximizes contributions of research participants.
• CAIRIBU (Collaborating for the Advancement of Interdisciplinary Research in Benign Urology)coreStrategic or Co-development PartnerCAIRIBU is an umbrella effort coordinated by the University of Wisconsin that coordinates the O'Brien Urology Centers Program, interactions with Urology K Programs, and the broader urology research community. The goal is to support transdisciplinary research and training of new investigators.
• University of Wisconsin - O'Brien Urology CentercoreStrategic or Co-development PartnerUniversity of Wisconsin Center's goal is to identify factors within the bladder and prostate that result in urinary dysfunction in aging men. Supports three research projects, pilot and feasibility program, summer research program, annual symposium, and Rodent Urinary Function Testing Core.
• Columbia University - O'Brien Urology CentercoreStrategic or Co-development PartnerColumbia University Center addresses questions related to genetic, cellular, and metabolic events that lead to lower urinary tract disorders (LUTS) and urinary tract infection (UTI), devising new methods for prevention and treatment. Supports three research projects, Microbial Genomics Biomedical Core, pilot and feasibility program, summer student research program, and mouse models for urologic disorders.
• Stanford University - O'Brien Urology Research CentercoreStrategic or Co-development PartnerStanford O'Brien Urology Research Center's goal is to utilize molecular and cellular methodologies to characterize and improve understanding of the pathophysiology of benign prostatic hyperplasia (BPH), and facilitate identification of specific treatments. Supports two research projects, Biospecimen/Bioimaging Core, pilot and feasibility program, and summer student research program.
• Urinary Stone Disease Research Network (USDRN)coreStrategic or Co-development PartnerNIDDK supports the Urinary Stone Disease Research Network (USDRN) as part of its urologic disease research programs, conducting collaborative research on urinary stone disease.
• Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN)coreStrategic or Co-development PartnerNIDDK supports the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) as part of its urologic disease research programs, conducting research on lower urinary tract symptoms.
• Multi-Disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research NetworkcoreStrategic or Co-development PartnerNIDDK supports the MAPP Research Network as part of its urologic disease research programs, conducting research on chronic pelvic pain syndromes.
• Prevention of Lower Urinary Tract Symptoms (PLUS) ConsortiumcoreStrategic or Co-development PartnerNIDDK supports the PLUS Consortium as part of its urologic disease research programs, conducting research on prevention of lower urinary tract symptoms in women and girls.
• University of Virginia Center for Diabetes TechnologycoreStrategic or Co-development PartnerUVA researchers, in collaboration with NIDDK, conducted a review showing that automated insulin delivery systems like artificial pancreas have helped type 1 diabetes patients manage blood sugar, with plans for fully automated AID systems testing AI-driven algorithms.
• Booz Allen HamiltonminorImplementation/ SI/ Consulting PartnerBooz Allen Hamilton, as NIDDK Central Repository contractor, has piloted a natural language processing (NLP) pipeline project for harmonizing study variables with NIH CDEs and identifying potential new CDEs from dataset variables.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• National Institute of Mental Health (NIMH): NIMH is a peer NIH institute combining intramural science, extramural grants, consortium clinical trials, and an authoritative health information function. Operates under the same federal appropriations pipeline and Congressional authorization, providing one of the cleanest structural comparables for NIDDK's operating model.
• National Cancer Institute (NCI): NCI is a sibling NIH institute conducting and funding biomedical research, with intramural labs, extramural grants, and a Central Repository structure analogous to NIDDK's. It operates under identical federal authority and Congressional appropriations model, making it the closest structural peer across disease area.
• National Heart, Lung, and Blood Institute (NHLBI): NHLBI is another peer NIH institute with the same combination of intramural research, investigator-initiated extramural funding, clinical trial networks, and a research data repository. Comparable scale and operating model, focused on cardiovascular, pulmonary, and hematologic disease.
• National Institute of Allergy and Infectious Diseases (NIAID): NIAID mirrors NIDDK's structure: NIH-congressionally-authorized institute funding basic and clinical research, maintaining consortia (analogous to DPP, TEDDY, TrialNet), and supporting extensive biomarker/diagnostic research. Comparable in budget, footprint, and operating mechanics.
• National Institute on Aging (NIA): NIA is a peer NIH institute with intramural programs, large extramural grant portfolios, investigator training, and a public health information clearinghouse. NIDDK's diabetes/obesity aging overlap (e.g., CKD, T2D in older adults) and shared federal governance make NIA a near-direct peer for operating model comparison.
• Howard Hughes Medical Institute (HHMI): HHMI is the largest U.S. private biomedical research organization, comparable to NIDDK in scientific breadth, scale (~$2B+ annual research budget), investigator-driven model, and translational mission. Comparable peer for non-government biomedical research funding and scientific leadership in the U.S. ecosystem.

Broad incumbents

• National Institutes of Health (NIH): NIH is NIDDK's parent umbrella organization; it operates the same federal research-funding and -conducting model at much greater scale (~$47B annual budget). It contextualizes NIDDK as one component of a broader biomedical research portfolio rather than a direct competitor.

Regional players

• Medical Research Council (UK): The UK MRC is the closest international governmental analog: a national research council that funds biomedical research, supports intramural units, and runs investigator-initiated grant programs across disease areas. Operates a similar translational research model in a different geography (UK), making it the strongest regional peer for benchmarking.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/NIDDKgov

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments56 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute of Diabetes and Digestive and Kidney Diseases